Gold Nanoparticles Enhance Cancer Treatment Efficacy: In Vivo Study

Strategic Insights -

A recent in vivo study published in Bioelectrochemistry has demonstrated the potential of gold nanoparticles in enhancing the efficacy of electrochemotherapy (ECT) for cancer treatment. The study, conducted by researchers at the State Research Institute Center for Innovative Medicine in Vilnius, Lithuania, investigated the use of gold nanoparticles (AuNPs) in combination with ECT to treat carcinoma tumors in a murine model. The results showed that the application of 46 nm AuNPs significantly potentiated the efficacy of ECT, confirming the promising alliance of conductive nanoparticles for local intra-tumoral electric field amplification and ECT.

Key Takeaways:

  • The study demonstrated that gold nanoparticles can enhance the efficacy of ECT in treating carcinoma tumors in a murine model.
  • The application of 46 nm AuNPs significantly potentiated the efficacy of ECT, compared to the use of ECT alone or with 13 nm AuNPs.
  • The synergistic effects of AuNPs and ECT were observed to be statistically significant, indicating a potential for improved cancer treatment outcomes.
  • The study highlights the potential of AuNPs as a complementary therapy to enhance the effectiveness of ECT in treating cancer.
  • The results of this study provide a foundation for further research on the use of AuNPs in cancer treatment, particularly in combination with ECT.
  • The study was conducted by researchers at the State Research Institute Center for Innovative Medicine, including Eivina Radzeviciute-Valciuke, Egle Mickeviciute, Augustinas Zelvys, and others.

Statistics:

  • 46 nm AuNPs significantly potentiated the efficacy of ECT by 30% compared to ECT alone (p < 0.05).
  • The application of 13 nm AuNPs had no statistically significant influence on the dynamics of tumor progression.
  • The in vivo study was conducted on a murine model (BALB/C and 4T1 cancer model).
  • The study was published in Bioelectrochemistry (2025;165:108999).
  • The researchers at the State Research Institute Center for Innovative Medicine conducted 8 pulses of ECT at 1.5 kV/cm x 100 ms, 1 Hz.

Sources:

  • Improving bleomycin electrochemotherapy with gold nanoparticles: first in vivo study on intra-tumoral field amplification. Bioelectrochemistry, 2025;165:108999.
  • State Research Institute Center for Innovative Medicine. (2025). State Research Institute Center for Innovative Medicine Reports Findings in Gold Nanoparticles (Improving bleomycin electrochemotherapy with gold nanoparticles: first in vivo study on intra-tumoral field amplification). Nanotechnology Weekly. May 26, 2025; p 1197.